Bioceltix (WAR:BCX) Valuation Rank


WAR:BCX Bioceltix SA WAR:BCX
26 GF Score
Price zł90.40
! 1 Warning Sign
View Full Analysis

What is Bioceltix Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Bioceltix Valuation Rank Related Terms

WAR:BCX
26GF Score
Bioceltix SA WAR:BCX
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioceltix Business Description

Address Bierutowska 57-59 Street, Wroclaw, POL, 51-317
Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.
26GF Score

Get the complete analysis for WAR:BCX

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł90.40
Price